X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
female (12) 12
male (12) 12
adult (11) 11
middle aged (11) 11
aged (10) 10
oncology (8) 8
index medicus (7) 7
aged, 80 and over (6) 6
immunology (6) 6
analysis (4) 4
kinases (4) 4
leukemia (4) 4
medicine & public health (4) 4
melanoma - immunology (4) 4
ap24534 (3) 3
cancer (3) 3
care and treatment (3) 3
epitopes, t-lymphocyte - immunology (3) 3
gp100 melanoma antigen (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
imidazoles - administration & dosage (3) 3
imidazoles - adverse effects (3) 3
lung neoplasms - drug therapy (3) 3
melanoma - therapy (3) 3
metastatic melanoma (3) 3
patients (3) 3
peptides (3) 3
ponatinib (3) 3
protein kinase inhibitors - therapeutic use (3) 3
pyridazines - administration & dosage (3) 3
pyridazines - adverse effects (3) 3
resistance (3) 3
t-lymphocytes, cytotoxic - immunology (3) 3
treatment outcome (3) 3
tyrosine kinase inhibitor (3) 3
adolescent (2) 2
animals (2) 2
antigens, neoplasm (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
bosutinib (2) 2
brain metastases (2) 2
cancer research (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
chronic myeloid leukemia (2) 2
chronic myeloid-leukemia (2) 2
combination (2) 2
cytolytic t-lymphocytes (2) 2
dasatinib (2) 2
dendritic cells - immunology (2) 2
dendritic cells - metabolism (2) 2
diagnosis (2) 2
disease (2) 2
dose-response relationship, drug (2) 2
genetic aspects (2) 2
hla-a2 antigen - immunology (2) 2
imatinib (2) 2
imidazoles - therapeutic use (2) 2
internal medicine (2) 2
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (2) 2
leukocytes, mononuclear - immunology (2) 2
lung cancer (2) 2
lung neoplasms - genetics (2) 2
medical colleges (2) 2
medical research (2) 2
medicine, general & internal (2) 2
melanoma (2) 2
melanoma - genetics (2) 2
membrane glycoproteins - immunology (2) 2
metastasis (2) 2
mutation (2) 2
neoplasm proteins - genetics (2) 2
neoplasm proteins - immunology (2) 2
neutropenia (2) 2
peptide fragments - immunology (2) 2
peptide fragments - metabolism (2) 2
pharmacokinetics (2) 2
pharmacology & pharmacy (2) 2
pharmacology/toxicology (2) 2
philadelphia chromosome (2) 2
protein binding - immunology (2) 2
protein kinase inhibitors - adverse effects (2) 2
pyridazines - therapeutic use (2) 2
research institutes (2) 2
sensitivity and specificity (2) 2
thrombocytopenia (2) 2
tumor-infiltrating lymphocytes (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
accuracy (1) 1
acute lymphatic leukemia (1) 1
acute myeloid leukaemia (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenoviruses, human - genetics (1) 1
adenoviruses, human - immunology (1) 1
administration, oral (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1683 - 1696
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 612 - 621
Journal Article
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2009, Volume 84, Issue 11, pp. 985 - 1000
Many proliferative, invasive, and immune tolerance mechanisms that support normal human pregnancy are also exploited by malignancies to establish a nutrient... 
Internal Medicine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 21, pp. 2129 - 2139
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2010, Volume 65, Issue 4, pp. 765 - 773
Insulin-like growth factor 1 receptor signaling through upregulation of the stimulatory ligand IGF-II has been implicated in the pathogenesis of adrenocortical... 
Medicine & Public Health | Adrenocortical carcinoma | CP-751,871 | Oncology | Cancer Research | Monoclonal antibody | Pharmacology/Toxicology | IGF-1R | Figitumumab | CELLS | INDUCED APOPTOSIS | COMBINATION | BREAST-CANCER | INSULIN-RECEPTOR | ONCOLOGY | IGF RECEPTOR | PHARMACOLOGY & PHARMACY | PHASE-I | EXPRESSION | GROWTH-FACTOR-I | Adrenal Cortex Neoplasms - blood | Receptor, IGF Type 1 - antagonists & inhibitors | Nausea - chemically induced | Area Under Curve | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Metabolic Clearance Rate | Fatigue - chemically induced | Insulin - blood | Young Adult | Adrenocortical Carcinoma - pathology | Adrenocortical Carcinoma - drug therapy | Hyperglycemia - chemically induced | Adult | Female | Growth Hormone - blood | Drug Administration Schedule | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Adrenal Cortex Neoplasms - pathology | Adrenal Cortex Neoplasms - drug therapy | Antibodies, Monoclonal - administration & dosage | Receptor, IGF Type 1 - immunology | Anorexia - chemically induced | Aged | Infusions, Intravenous | Adrenocortical Carcinoma - blood | Immunoglobulins, Intravenous | Cohort Studies | Complications and side effects | Somatotropin | Hyperglycemia | Care and treatment | Safety and security measures | Carcinoma | Analysis | Monoclonal antibodies | Glucose | Metastasis | Dextrose | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article